Emmaus Holdings, Inc. S-1/AEmmaus Life Sciences, Inc. • October 6th, 2011 • Blank checks • California
THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.
Promissory Note (Cash Interest) (On Demand)Emmaus Life Sciences, Inc. • October 6th, 2011 • Blank checks • California
FOR VALUE RECEIVED, Emmaus Medical, Inc., a Delaware corporation, located at 20725 S. Western Ave., Suite 136, Torrance, CA 90501 (“Borrower”) agrees to pay to Yoko Hagiike (“Lender”), the sum of $__________ U.S. Dollars (“Principal Amount”), together with accrued interest thereon at the rate of ten percent (10%) per annum, under the following terms and conditions of this Promissory Note (“Note”).
ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (the “Agreement”) By and Between CELLSEED INC. (“CELLSEED”) And EMMAUS MEDICAL INC. (“EMMAUS”)Joint Research and Development Agreement • October 6th, 2011 • Emmaus Life Sciences, Inc. • Blank checks
NOW, THEREFORE, in consideration of the mutual promises and undertakings set forth herein, and intending to be legally bound hereby, CELLSEED and EMMAUS do hereby agree and acknowledge as follows:
